The utility of routine endocrinopathy testing in patients treated with ipilimumab for solid malignancies.
2020
e19250Background: It is recommended to periodically screen for endocrine immune-related adverse events during the administration of ipilimumab(ipi) and nivolumab(nivo) immunotherapy. ACTH and TSH l...
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI